NEW YORK (GenomeWeb) – Oxford Nanopore Technologies said today that it is expanding its business in China, naming Shanghai NanodigmBio as a distributor of its sequencing products and services and preparing to open a new office in Shanghai this year.

Oxford Nanopore already has commercial and support staff based in China, and said that several Chinese customers have been installing the GridIon X5 sequencing platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.